受体阻滞剂-话题@MedSci

#受体阻滞剂#

148篇内容 | 3265人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1995201, encodeId=d70a199520145, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=β受体阻滞剂治疗高血压的临床应用建议, objectType=article, longId=177194, objectId=81581e7194c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81581e7194c3, replyNumber=0, likeNumber=28, createdTime=2019-08-13, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81581e7194c3, moduleTitle=β受体阻滞剂治疗高血压的临床应用建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81581e7194c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995189, encodeId=a8f11995189ec, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险, objectType=article, longId=151179, objectId=10aa1511e908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10aa1511e908, replyNumber=0, likeNumber=68, createdTime=2019-02-10, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10aa1511e908, moduleTitle=Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10aa1511e908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995186, encodeId=4c9e199518622, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择, objectType=article, longId=149357, objectId=2f0e14935ebb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f0e14935ebb, replyNumber=0, likeNumber=69, createdTime=2019-05-29, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f0e14935ebb, moduleTitle=JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f0e14935ebb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995188, encodeId=429e199518873, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响, objectType=article, longId=150404, objectId=af2015040478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af2015040478, replyNumber=0, likeNumber=60, createdTime=2019-06-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af2015040478, moduleTitle=Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af2015040478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995191, encodeId=b7031995191de, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, objectType=article, longId=152882, objectId=97e515288294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e515288294, replyNumber=0, likeNumber=94, createdTime=2019-06-09, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e515288294, moduleTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97e515288294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995196, encodeId=6db71995196e8, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布, objectType=article, longId=162908, objectId=a3c81629085d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c81629085d, replyNumber=0, likeNumber=57, createdTime=2019-09-13, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c81629085d, moduleTitle=2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3c81629085d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995190, encodeId=3e0c199519032, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率, objectType=article, longId=151198, objectId=77581511982e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77581511982e, replyNumber=0, likeNumber=58, createdTime=2019-06-25, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77581511982e, moduleTitle=Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77581511982e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995199, encodeId=32e519951993b, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性, objectType=article, longId=168960, objectId=a861168960b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a861168960b7, replyNumber=0, likeNumber=71, createdTime=2019-11-30, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a861168960b7, moduleTitle=JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a861168960b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995198, encodeId=0ba71995198ed, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率, objectType=article, longId=166800, objectId=cf8f166800fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf8f166800fa, replyNumber=0, likeNumber=82, createdTime=2019-09-18, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf8f166800fa, moduleTitle=2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf8f166800fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995192, encodeId=0aab19951927a, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Circulation：ACS合并CKD：P2Y12-ADP受体阻滞剂疗效如何？, objectType=article, longId=153171, objectId=ed171531e1f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed171531e1f1, replyNumber=0, likeNumber=121, createdTime=2019-01-15, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed171531e1f1, moduleTitle=Circulation：ACS合并CKD：P2Y12-ADP受体阻滞剂疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed171531e1f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995184, encodeId=8c1219951844a, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=2018 临床实践指南：α受体阻滞剂治疗单纯性输尿管结石, objectType=article, longId=144578, objectId=630e1445e89b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=630e1445e89b, replyNumber=0, likeNumber=34, createdTime=2018-09-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=630e1445e89b, moduleTitle=2018 临床实践指南：α受体阻滞剂治疗单纯性输尿管结石, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=630e1445e89b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995194, encodeId=4e151995194f6, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系, objectType=article, longId=157152, objectId=5a6115e152ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a6115e152ee, replyNumber=0, likeNumber=64, createdTime=2019-03-08, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a6115e152ee, moduleTitle=Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a6115e152ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995183, encodeId=c4c519951835a, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=循证证据夯实地位：高选择性β1受体阻滞剂心血管获益更佳, objectType=article, longId=144355, objectId=6914144355ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6914144355ff, replyNumber=0, likeNumber=66, createdTime=2019-03-05, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6914144355ff, moduleTitle=循证证据夯实地位：高选择性β1受体阻滞剂心血管获益更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6914144355ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995178, encodeId=34e619951e8f2, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=糖尿病患者：我能不能用β受体阻滞剂？, objectType=article, longId=133855, objectId=52b31338551a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52b31338551a, replyNumber=0, likeNumber=69, createdTime=2019-01-01, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52b31338551a, moduleTitle=糖尿病患者：我能不能用β受体阻滞剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52b31338551a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995187, encodeId=b8e0199518e63, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？, objectType=article, longId=150169, objectId=8923150169bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8923150169bb, replyNumber=0, likeNumber=66, createdTime=2019-07-25, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8923150169bb, moduleTitle=JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8923150169bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995185, encodeId=3fc01995185bd, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Sci Rep：下尿路症状/良性前列腺增生治疗中，α-受体阻滞剂处方方式研究, objectType=article, longId=148514, objectId=5e19148514a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e19148514a7, replyNumber=0, likeNumber=69, createdTime=2019-05-25, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e19148514a7, moduleTitle=Sci Rep：下尿路症状/良性前列腺增生治疗中，α-受体阻滞剂处方方式研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e19148514a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995168, encodeId=2c19199516877, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=急性心力衰竭时，β受体阻滞剂——用还是不用？这是个问题！, objectType=article, longId=123333, objectId=ba9f1233334d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba9f1233334d, replyNumber=0, likeNumber=113, createdTime=2018-01-19, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba9f1233334d, moduleTitle=急性心力衰竭时，β受体阻滞剂——用还是不用？这是个问题！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba9f1233334d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995167, encodeId=837b199516eed, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Sci Tran Med：研究发现β受体阻滞剂对肺癌治疗具有极大的帮助！, objectType=article, longId=119435, objectId=6cd611943557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cd611943557, replyNumber=0, likeNumber=56, createdTime=2018-04-22, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cd611943557, moduleTitle=Sci Tran Med：研究发现β受体阻滞剂对肺癌治疗具有极大的帮助！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cd611943557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995181, encodeId=a2d8199518133, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Circ Cardiovasc Qual：急性心梗无心衰患者停用β-受体阻滞剂有何影响？, objectType=article, longId=139473, objectId=9e2f1394e3cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e2f1394e3cf, replyNumber=0, likeNumber=61, createdTime=2018-08-30, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e2f1394e3cf, moduleTitle=Circ Cardiovasc Qual：急性心梗无心衰患者停用β-受体阻滞剂有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e2f1394e3cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995182, encodeId=2d7e19951827d, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, objectType=article, longId=141676, objectId=ab751416e6bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab751416e6bd, replyNumber=0, likeNumber=83, createdTime=2019-04-18, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab751416e6bd, moduleTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab751416e6bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

受体阻滞剂

2020-05-29

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

β受体阻滞剂治疗高血压的临床应用建议

2019-08-13

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险

2019-02-10

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择

2019-05-29

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响

2019-06-20

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系

2019-06-09

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布

2019-09-13

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率

2019-06-25

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性

2019-11-30

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率

2019-09-18

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Circulation：ACS合并CKD：P2Y12-ADP受体阻滞剂疗效如何？

2019-01-15

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

2018 临床实践指南：α受体阻滞剂治疗单纯性输尿管结石

2018-09-06

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系

2019-03-08

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

循证证据夯实地位：高选择性β1受体阻滞剂心血管获益更佳

2019-03-05

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

糖尿病患者：我能不能用β受体阻滞剂？

2019-01-01

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？

2019-07-25

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Sci Rep：下尿路症状/良性前列腺增生治疗中，α-受体阻滞剂处方方式研究

2019-05-25

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

急性心力衰竭时，β受体阻滞剂——用还是不用？这是个问题！

2018-01-19

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Sci Tran Med：研究发现β受体阻滞剂对肺癌治疗具有极大的帮助！

2018-04-22

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Circ Cardiovasc Qual：急性心梗无心衰患者停用β-受体阻滞剂有何影响？

2018-08-30

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！

2019-04-18

科室
- - 订阅+
  - 更多科室
工具
服务